At Roche Pharmaceuticals, we focus on finding new medicines that help patients live longer, better lives and evolve the practice of medicine.
This page lists Roche Australia’s pharmaceutical medicines. Use the search function to search by active ingredient, brand name or disease area, to find the Product Information (PI) and Consumer Medicine Information (CMI) for each product.
- Actemra® (tocilizumab)
-
Actemra® (tocilizumab)
Availability of Actemra® (tocilizumab):
- Pre-filled syringe for subcutaneous (SC) injection
- Pre-filled pen for subcutaneous (SC) injection
- Intravenous (IV) solution for infusion
Actemra® (tocilizumab) pre-filled syringe for subcutaneous (SC) injection
Patients
Consumer Medicine Information (CMI)Healthcare Professionals
Product Information (PI)Actemra® (tocilizumab) pre-filled pen for subcutaneous (SC) injection
Patients
Consumer Medicine Information (CMI)Healthcare Professionals
Product Information (PI)Actemra® (tocilizumab) intravenous (IV) solution for infusion
Patients
Consumer Medicine Information (CMI)Healthcare Professionals
Product Information (PI) - Alecensa® (alectinib)
-
Alecensa® (alectinib)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Avastin® (bevacizumab)
-
Avastin® (bevacizumab)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - CellCept® (mycophenolate mofetil)
-
CellCept® (mycophenolate mofetil)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Cotellic® (cobimetinib)
-
Cotellic® (cobimetinib)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Enspryng® (satralizumab)
-
Enspryng® (satralizumab)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Erivedge® (vismodegib)
-
Erivedge® (vismodegib)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Esbriet® (pirfenidone)
-
Esbriet® (pirfenidone)
Availability of Esbriet® (pirfenidone):
- Tablets
- Capsules
Esbriet® (pirfenidone) tablets
Patients
Consumer Medicine Information (CMI)Healthcare Professionals
Product Information (PI)Esbriet® (pirfenidone) capsules
Patients
Consumer Medicine Information (CMI)Healthcare Professionals
Product Information (PI) - Evrysdi® (risdiplam)
-
Evrysdi® (risdiplam)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Fuzeon® (enfuvirtide)
-
Fuzeon® (enfuvirtide)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Gazyva® (obinutuzumab)
-
Gazyva® (obinutuzumab)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Hemlibra® (emicizumab)
-
Hemlibra® (emicizumab)
Patients
Consumer Medicine Information (CMI)Healthcare Professionals
Product Information (PI) - Herceptin® (trastuzumab) powder for IV infusion
-
Herceptin® (trastuzumab) powder for IV infusion
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Herceptin® SC (trastuzumab) solution for SC injection
-
Herceptin® SC (trastuzumab) solution for SC injection
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Invirase® (saquinavir)
-
Invirase® (saquinavir)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
- Kadcyla® (trastuzumab emtansine)
-
Kadcyla® (trastuzumab emtansine)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - MabThera® (rituximab) solution for IV infusion
-
MabThera® (rituximab) solution for IV infusion
Patients
NHL/CLL Consumer Medicine Information (CMI)
RA/GPA/MPA Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - MabThera® SC (rituximab) solution for SC injection
-
MabThera® SC (rituximab) solution for SC injection
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Madopar® (levodopa and benserazide)
-
Madopar® (levodopa and benserazide)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Mircera® (methoxy polyethylene glycolepoetin beta)
-
Mircera® (methoxy polyethylene glycolepoetin beta)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - NeoRecormon® (epoetin beta)
-
NeoRecormon® (epoetin beta)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Ocrevus® (ocrelizumab)
-
Ocrevus® (ocrelizumab)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Pegasys® (peginterferon alfa-2a)
-
Pegasys® (peginterferon alfa-2a)
In May 2022, Roche transferred the sponsorship and management of supply, customer support, medical information, regulatory services, sales and marketing of Pegasys to Echo Therapeutics Pty Ltd in Australia. The current Consumer Medicine Information (CMI) and Product Information (PI) for Pegasys are available from the Therapeutic Goods Administration (TGA) website at: https://www.ebs.tga.gov.au/
- Perjeta® (pertuzumab)
-
Perjeta® (pertuzumab)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Polivy® (polatuzumab vedotin)
-
Polivy® (polatuzumab vedotin)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Pulmozyme® (dornase alfa)
-
Pulmozyme® (dornase alfa)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Rivotril® (clonazepam)
-
Rivotril® (clonazepam)
In August 2021, Roche transferred the sponsorship and management of supply, customer support, medical information, regulatory services, sales and marketing of Rivotril (clonazepam) to Pharmaco Australia Ltd within Australia. The current Consumer Medicine Information (CMI) and Product Information (PI) for Valium are available from the Therapeutic Goods Administration (TGA) website at: https://www.ebs.tga.gov.au/
- Roaccutane® (isotretinoin)
-
Roaccutane® (isotretinoin)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Rocaltrol® (calcitriol)
-
Rocaltrol® (calcitriol)
Please be advised that Roche has transitioned responsibility of Rocaltrol to Atnahs. Please contact Atnahs for the current Product Information (PI) and Consumer Medicine Information (CMI).
- Ronapreve® (casirivimab and imdevimab)
-
Ronapreve® (casirivimab and imdevimab)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Rozlytrek® (entrectinib)
-
Rozlytrek® (entrectinib)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Tamiflu® (oseltamivir) capsules
-
Tamiflu® (oseltamivir) capsules
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Tamiflu® (oseltamivir) suspension
-
Tamiflu® (oseltamivir) suspension availability - 26 June 2019
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Tarceva® (erlotinib)
-
Tarceva® (erlotinib)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Tecentriq® (atezolizumab)
-
Tecentriq® (atezolizumab)
Roche update on Phase III study of Tecentriq in combination with paclitaxel for people with metastatic triple-negative breast cancer - IMpassion131 results.
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Vabysmo® (faricimab)
-
Vabysmo® (faricimab)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Valcyte® (valganciclovir) powder for oral solution
-
Valcyte® (valganciclovir) powder for oral solution
In September 2022, Roche transferred the sponsorship and management of supply, customer support, medical information, regulatory services, sales and marketing of Valcyte 50 mg/mL powder for oral solution to Pharmaco (Australia) Ltd in Australia. The current Consumer Medicine Information (CMI) and Product Information (PI) for Valcyte are available from the Therapeutic Goods Administration (TGA) website at: www.ebs.tga.gov.au
- Valcyte® (valganciclovir) tablets
-
Valcyte® (valganciclovir) tablets
In September 2022, Roche transferred the sponsorship and management of supply, customer support, medical information, regulatory services, sales and marketing of Valcyte 450 mg tablet to Pharmaco (Australia) Ltd in Australia. The current Consumer Medicine Information (CMI) and Product Information (PI) for Valcyte are available from the Therapeutic Goods Administration (TGA) website at: www.ebs.tga.gov.au
- Valium® (diazepam)
-
Valium® (diazepam)
In August 2021, Roche transferred the sponsorship and management of supply, customer support, medical information, regulatory services, sales and marketing of Valium (diazepam) to Atnahs Pharma Australia Pty Ltd within Australia. The current Consumer Medicine Information (CMI) and Product Information (PI) for Valium are available from the Therapeutic Goods Administration (TGA) website at: www.ebs.tga.gov.au
- Xofluza® (Baloxavir marboxil)
-
Xofluza® (baloxavir marboxil)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI) - Zelboraf® (vemurafenib)
-
Zelboraf® (vemurafenib)
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI)